HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species.

Abstract
Cloretazine [1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine; VNP40101M; 101M] is a relatively new prodrug with activity in elderly acute myelogenous leukemia (AML) patients. Its therapeutic action is due largely to the production of 1-(3-cytosinyl),2-(1-guanyl)ethane cross-links (G-C ethane cross-links) in DNA. The numbers of cross-links produced in three experimental leukemia lines (L1210, U937 and HL-60) were fewer than 10 per genome at their respective LC50 concentrations. Only 1 in approximately 20,000 90CE molecules produces a cross-link in the AGT (O6-alkylguanine-DNA alkyltransferase) negative L1210 and U937 cell lines and 1 in 400,000 in the AGT positive HL-60 cell line.
AuthorsPhilip G Penketh, Raymond P Baumann, Kimiko Ishiguro, Krishnamurthy Shyam, Helen A Seow, Alan C Sartorelli
JournalLeukemia research (Leuk Res) Vol. 32 Issue 10 Pg. 1546-53 (Oct 2008) ISSN: 0145-2126 [Print] England
PMID18479747 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine
  • Antineoplastic Agents
  • Cross-Linking Reagents
  • Hydrazines
  • Sulfonamides
  • laromustine
  • Guanine
  • Cytosine
  • DNA
  • Ethane
Topics
  • Animals
  • Antineoplastic Agents (chemistry, therapeutic use, toxicity)
  • Cell Line, Tumor
  • Cross-Linking Reagents (chemistry, toxicity)
  • Cytosine (chemistry)
  • DNA (chemistry)
  • Ethane (chemistry)
  • Guanine (chemistry)
  • HL-60 Cells
  • Humans
  • Hydrazines (chemistry, therapeutic use, toxicity)
  • Leukemia (drug therapy)
  • Mice
  • Sulfonamides (chemistry, therapeutic use, toxicity)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: